SCHEMBL28634046

SCHEMBL28634046

Cc1cccc(F)c1-c1cc2c(-c3cnn(C4CCNCC4)c3)cnc(N)c2cc1C#N

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAP4K3 Q8IVH8 6/20 0.59
MAP3K7 O43318 4/20 0.49
TAB1 Q15750 4/20 0.49
ACVRL1 P37023 5/20 0.47
ACVR1 Q04771 5/20 0.47
MET P08581 1/20 0.44
BMPR1A P36894 2/20 0.44
ALK Q9UM73 1/20 0.44
CHRNB2 P17787 1/20 0.43
CHRNA4 P43681 1/20 0.43
GRK2 P25098 1/20 0.42
GRK5 P34947 1/20 0.42
NTRK1 P04629 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29929924 0.88 MAP3K7 (0.47) MAP4K3MAP3K7TAB1
SCHEMBL28927885 0.87 MAP4K3 (0.43) MAP4K3MAP3K7TAB1ACVRL1ACVR1
SCHEMBL28636439 0.85 MAP3K7 (0.51) MAP4K3MAP3K7TAB1
SCHEMBL28962175 0.84 KDM1A (0.45) MAP4K3ACVRL1ACVR1METALK
SCHEMBL28927859 0.81 MAP3K7 (0.45) MAP4K3MAP3K7TAB1
SCHEMBL28638645 0.79 MAP4K3 (0.39) MAP4K3CHRNB2CHRNA4
SCHEMBL28927866 0.75 MAP4K1 (0.46) ACVRL1ACVR1BMPR1A
SCHEMBL28927864 0.75 PIM1 (0.43)
SCHEMBL28633555 0.73 MAP4K1 (0.42)
SCHEMBL29929741 0.73 MAP4K1 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115244050-B Novel HPK1 inhibitor and preparation method and application thereof 轶诺(浙江)药业有限公司 2024-06-21 CN disclosed
CN-115244050-A Novel HPK1 inhibitor and preparation method and application thereof 轶诺(浙江)药业有限公司 2022-10-25 CN disclosed
CN-113336747-A Novel HPK1 inhibitor and preparation method and application thereof 轶诺(浙江)药业有限公司 2021-09-03 CN disclosed